| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |